ClinicalTrials.gg
CompletedNCT07947017Updated Nov 18, 2026

Development of the Sleep Cycle App's Tracking Abilities of Sleep and Sleep Behaviors

An observational study in Sleep Apnea, Obstructive, sponsored by Sleep Cycle AB. Completed at 1 site in Australia. Open to participants aged 22 Years to 70 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-18.

Sponsored by Sleep Cycle AB · Observational

Updated Nov 18, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Case-control
Time perspective
Cross-sectional
Enrollment
324
Ages
22 Years to 70 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-19

Among 63 studies in Sleep Apnea, Obstructive with a site in Australia — 16 open to participants now, 19 under way, 6 of them phase 3. Sleep Apnea, Obstructive · Australia.

Started
2025
with 9 others
Observational
6 of 63
3 open now
Registered
63rd of 63
by date

Among the 63 studies in Sleep Apnea, Obstructive with a site in Australia, this one is one of 10 that started in 2025, is one of 6 observational ones, and was the 63rd registered.

Sleep Apnea, Obstructive

2,245 studies on the registry are indexed under Sleep Apnea, Obstructive; 476 are open to participants now.

Browse Sleep Apnea, Obstructive studies →

Open to participants now

16 of the 63 studies in Sleep Apnea, Obstructive with a site in Australia are open now. Recruiting first, the newest first:

11 more — sign in →

All 16 open studies →

A study can be open while its sites in Australia have not opened yet or have stopped. Only those recruiting at a site in Australia →

Who these studies take

Of the 316 Sleep Apnea, Obstructive studies recruiting now, 149 (47%) set no upper age limit and 123 (39%) stop at 75 or younger; 52 take children under 18; 66 take healthy volunteers.

This study: 22 Years to 70 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 63 studies in Sleep Apnea, Obstructive with a site in Australia, or all of them as a file.
02

Study summary

The present study seeks to develop the software function of Sleep Cycle's app to estimate risk of obstructive sleep apnea (OSA) compared to polysomnography (PSG) in adults in an over-the-counter setting (i.e., home environment). The main questions it aims to answer are:

  1. To develop the Sleep Cycle app's function to differentiate between subjects with a 'high risk of sleep apnea [i.e., an Apnea-Hypopnea Index (AHI) of 15 or more]' vs subjects with 'low risk of sleep apnea [i.e., AHI \< 15], and
  2. To develop an algorithm to distinguish between wake vs sleep, as well as classifying different sleep stages (ie, light sleep [N1 and N2] vs deep sleep [N3] vs Rapid Eye Movement (REM) sleep).

Researchers will compare Sleep Cycle's app to PSG (gold standard measure of diagnosing sleep apnea and measuring sleep stages) to see if Sleep Cycle's app can estimate the risk of sleep apnea.

Researchers will evaluate the sensitivity and specificity of the app to determine the research aims by comparing 2 groups: adults with an AHI \<15 and adults with an AHI of 15 or more.

Participants will:

Undertake one night of at-home PSG with 3x additional technologies: Sleep Cycle app on iPhone next to their bed + an audio recorder (both to record audio), and wear an Apple Watch to measure physiological measures (eg, heart rate).

03

Conditions studied

  • Sleep Apnea, Obstructive
04

Who can participate

Ages eligible
22 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Members of the community who have been referred to Sleep Testing Australia for a sleep study with suspected sleep apnea. These people will have been referred by their GP for an overnight PSG. They would receive this routine care whether they chose to participate in the study or not.

And adults from the community who self-identify as "good sleepers".

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • age 22-70
  • willing to sleep alone on night of testing
  • willing to abstain from consuming alcohol on the night of testing
  • have not previously been diagnosed with sleep apnea
  • English-speaking

Exclusion criteria

Exclusion Criteria:

  • do not meet inclusion criteria.
  • diagnosis of a chronic movement, cardiac or respiratory condition
  • temporary respiratory symptoms (e.g., influenza)
  • pregnant
  • medications that can influence AHI (e.g., reduce or increase frequency of AHI) based on evidence from published peer-reviewed articles
05

Study design

Observational model
Case-control
Time perspective
Cross-sectional
Enrollment
324 participants (actual)
Patient registry
No

Groups and cohorts

  • At-risk of significant sleep apnea

    Participants who are referred to Sleep Testing Australia for a sleep study as part of their routine care/as referred by their general practitioner (GP). Methods and materials will be the same as other cohort - i.e., PSG, Sleep Cycle app, audio recorder and Apple Watch

    Diagnostic Test: Sleep Apnea Screening

  • None-to-low risk of sleep apnea

    Healthy good sleepers or those with mild sleep apnea of approximately same age/gender as the other cohort who are willing to undergo methods and materials as part of routine care of other cohort (i.e., sleep study PSG, Sleep Cycle app, audio recorder and Apple Watch).

    Diagnostic Test: Sleep Apnea Screening

Interventions

  • Diagnostic testSleep Apnea Screening

    Sleep Cycle app with sleep apnea screening feature

06

What researchers measure

Primary outcomes

  1. AHI (Apnea-Hypopnea Index)

    The AHI will be determined by the gold-standard polysomnography (PSG), and independently predicted by the Sleep Cycle app.

    Time frame: During one overnight sleep study (one night)

Secondary outcomes

  1. Sleep-wake stage

    The detection of wake vs 1 of 4 sleep stages (N1, N2, N3, REM sleep) will be measured by the gold-standard PSG, and independently predicted by the Sleep Cycle app.

    Time frame: During one overnight sleep study (one night)

  2. Heart Rate

    Measured by ECG as part of PSG \& Apple Watch

    Time frame: During one overnight sleep study (one night)

07

Study locations

1 site
  • Sleep Testing Australia
    Brisbane, Queensland 4122, Australia
08

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from May 2025 to primary completion in Mar 2026, 9 months.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 9, 2026
First posted
Nov 18, 2026
StartActual
May 29, 2025
Primary completionActual
Mar 4, 2026
CompletionActual
Mar 4, 2026
Last update
Nov 18, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 18, 2026
Show all 1 update
  1. Nov 18, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT07947017
Lead sponsor
Sleep Cycle AB
Responsible party
Sponsor
First posted
Nov 18, 2026
Start date
May 29, 2025
Primary completion
Mar 4, 2026
Completion
Mar 4, 2026
Last update
Nov 18, 2026

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion